Talea Group S.p.A. (BIT:TALEA)
Italy · Delayed Price · Currency is EUR 4.800
0.00 (0.00%)
Last updated: Jan 20, 2026, 9:00 AM CET
Talea Group Revenue
In the year 2024, Talea Group had annual revenue of 132.17M EUR, down -4.89%. Talea Group had revenue of 53.15M in the half year ending December 31, 2024, a decrease of -16.29%.
Revenue
132.17M
Revenue Growth
-4.89%
P/S Ratio
0.31
Revenue / Employee
550.69K
Employees
240
Market Cap
40.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 132.17M | -6.79M | -4.89% |
| Dec 31, 2023 | 138.96M | 22.65M | 19.47% |
| Dec 31, 2022 | 116.31M | 33.83M | 41.01% |
| Dec 31, 2021 | 82.48M | 18.39M | 28.70% |
| Dec 31, 2020 | 64.09M | 26.45M | 70.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.55B |
| Amplifon | 2.41B |
| DiaSorin | 1.21B |
| EL.En. | 580.41M |
| GPI S.p.A. | 531.42M |
| Svas Biosana | 134.95M |
| Farmacosmo | 59.23M |
| EuKedos | 52.60M |